Clinical Research on Diabetic Complications
Refrigeration, air conditioning, and heat pumps (RACHP) have an important impact on the final energy uses of many sectors of modern society, such as residential, commercial, industrial, transport, and automotive. Moreover, RACHP also have an important environmental impact due to t...
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_68424 | ||
005 | 20210501 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20210501s2021 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-03943-826-6 | ||
020 | |a 9783039438259 | ||
020 | |a 9783039438266 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-03943-826-6 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a TBX |2 bicssc | |
100 | 1 | |a Mauricio, Didac |4 edt | |
700 | 1 | |a Mauricio, Didac |4 oth | |
245 | 1 | 0 | |a Clinical Research on Diabetic Complications |
260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2021 | ||
300 | |a 1 electronic resource (204 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Refrigeration, air conditioning, and heat pumps (RACHP) have an important impact on the final energy uses of many sectors of modern society, such as residential, commercial, industrial, transport, and automotive. Moreover, RACHP also have an important environmental impact due to the working fluids that deplete the stratospheric ozone layer, which are being phased out according to the Montreal Protocol (1989). Last, but not least, high global working potential (GWP), working fluids (directly), and energy consumption (indirectly) are responsible for a non-negligible quota of greenhouse gas (GHG) emissions in the atmosphere, thus impacting climate change. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a History of engineering & technology |2 bicssc | |
653 | |a burnt-out diabetes | ||
653 | |a chronic kidney disease (CKD) | ||
653 | |a dialysis | ||
653 | |a end-stage renal disease (ESRD) | ||
653 | |a incident diabetes mellitus (DM) | ||
653 | |a insulin resistance | ||
653 | |a dementia | ||
653 | |a dipeptidyl-peptidase IV inhibitors | ||
653 | |a diabetes mellitus | ||
653 | |a type 2 | ||
653 | |a Alzheimer's disease | ||
653 | |a vascular | ||
653 | |a diabetes | ||
653 | |a microperimetry | ||
653 | |a type 2 diabetes mellitus | ||
653 | |a glucose fluctuations | ||
653 | |a sarcopenia | ||
653 | |a diabetic retinopathy | ||
653 | |a type 1 diabetes | ||
653 | |a quality of life | ||
653 | |a treatment satisfaction | ||
653 | |a patient-reported outcomes | ||
653 | |a plaque characteristics | ||
653 | |a carotid plaque | ||
653 | |a echogenic plaque | ||
653 | |a diabetic foot syndrome | ||
653 | |a vascular disease | ||
653 | |a fibroblast growth factor 23 | ||
653 | |a Klotho | ||
653 | |a inflammation | ||
653 | |a dermal electrochemical conductance | ||
653 | |a neuropathy | ||
653 | |a primary care | ||
653 | |a screening | ||
653 | |a sudomotor reflex | ||
653 | |a prediabetes | ||
653 | |a arterial stiffness | ||
653 | |a baPWV | ||
653 | |a aspirin | ||
653 | |a primary prevention | ||
653 | |a meta-analysis | ||
653 | |a trial sequential analysis | ||
653 | |a sCD36 | ||
653 | |a type 1 diabetes mellitus | ||
653 | |a branched-chain amino acids | ||
653 | |a metabolomics | ||
653 | |a NMR spectroscopy | ||
653 | |a diabetic kidney disease | ||
653 | |a reno-cardiovascular protection | ||
653 | |a sodium-glucose co-transporter 2 inhibitors | ||
653 | |a glucagon-like peptide-1 receptor agonists | ||
653 | |a dipeptidyl peptidase 4 inhibitors | ||
653 | |a obesity | ||
653 | |a bariatric surgery | ||
653 | |a diabetic macroangiopathy | ||
653 | |a cardiovascular disease | ||
653 | |a heart disease | ||
653 | |a cerebrovascular disease | ||
653 | |a peripheral artery disease | ||
653 | |a diabetic foot disease | ||
653 | |a diabetic microangiopathy | ||
653 | |a diabetic neuropathy | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/3440 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/68424 |7 0 |z DOAB: description of the publication |